» Articles » PMID: 29247532

Gender Differences in the Association Between Discharge Hemoglobin and 12-month Mortality After Acute Myocardial Infarction

Overview
Journal Clin Cardiol
Date 2017 Dec 17
PMID 29247532
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anemia at discharge in patients with acute myocardial infarction is associated with poor prognosis; whether this differs in women and men or if there is a threshold value at which these relationships change is unknown.

Hypothesis: Women have a lower discharge hemoglobin (Hb) at which outcomes worsen.

Methods: We identified patients with acute myocardial infarction in the TRIUMPH registry between 2005 and 2008. In multivariable models, we evaluated the relationship between discharge Hb and 12-month mortality and tested whether this relationship varied by gender. We assessed whether the relationship with discharge Hb values was nonlinear using a restricted cubic spline term.

Results: Of 4243 patients with AMI, 32.9% were female. Mean admission Hb was 12.9 ± 1.9 g/dL in women and 14.5 ± 2.0 g/dL in men, with mean discharge Hb 11.4 ± 1.8 g/dL and 12.9 ± 1.9 g/dL, respectively. Lower discharge Hb was independently associated with increased mortality (P < 0.05). In multivariable models, discharge Hb decline was similarly associated with increased 12-month mortality in women and men (per 1-g/dL decrease Hb; women HR: 1.24, 95% CI: 1.09-1.42, P < 0.01; and men HR: 1.25, 95% CI: 1.13-1.37, P < 0.01; P for gender interaction = 0.99). The relationship between discharge Hb and 12-month mortality was linear (P for nonlinear spline term = 0.12).

Conclusions: Lower discharge Hb levels were similarly associated with increased 12-month mortality in women and men. These relationships are linear without a clear threshold, suggesting any decline in discharge Hb is associated with poor outcomes.

Citing Articles

Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.

Perrino C, Ferdinandy P, Botker H, Brundel B, Collins P, Davidson S Cardiovasc Res. 2020; 117(2):367-385.

PMID: 32484892 PMC: 7820844. DOI: 10.1093/cvr/cvaa155.


Gender differences in the association between discharge hemoglobin and 12-month mortality after acute myocardial infarction.

Thompson L, Masoudi F, Gosch K, Peterson P, Jones P, Salisbury A Clin Cardiol. 2017; 40(12):1279-1284.

PMID: 29247532 PMC: 6050984. DOI: 10.1002/clc.22824.

References
1.
Ndrepepa G, Berger P, Mehilli J, Seyfarth M, Neumann F, Schomig A . Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008; 51(7):690-7. DOI: 10.1016/j.jacc.2007.10.040. View

2.
McKechnie R, Smith D, Montoye C, Kline-Rogers E, ODonnell M, DeFranco A . Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation. 2004; 110(3):271-7. DOI: 10.1161/01.CIR.0000134964.01697.C7. View

3.
Aronson D, Suleiman M, Agmon Y, Suleiman A, Blich M, Kapeliovich M . Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J. 2007; 28(11):1289-96. DOI: 10.1093/eurheartj/ehm013. View

4.
Arnold S, Chan P, Jones P, Decker C, Buchanan D, Krumholz H . Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry. Circ Cardiovasc Qual Outcomes. 2011; 4(4):467-76. PMC: 3376532. DOI: 10.1161/CIRCOUTCOMES.110.960468. View

5.
Reynolds H, Farkouh M, Lincoff A, Hsu A, Swahn E, Sadowski Z . Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V. Arch Intern Med. 2007; 167(19):2054-60. DOI: 10.1001/archinte.167.19.2054. View